Aortic regurgitation occurs when blood leaks back into the left ventricle due to a leaky aortic valve. This is a type of valve disease in the heart. Aortic regurgitation can lead to some heart damage ...
Aortic insufficiency occurs when your aortic valve fails to close properly once the blood enters the aorta. This causes blood to flow the wrong way back into the heart. When the left ventricle doesn’t ...
Please provide your email address to receive an email when new articles are posted on . A novel system for transcatheter aortic valve replacement was safe and effective for a small cohort of patients ...
David Cohen moderates a panel on the ARTIST Trial, comparing TAVR with the Trilogy valve to SAVR in low/intermediate-risk aortic regurgitation patients. The discussion examines TAVR’s potential role ...
JenaValve has secured the FDA’s approval for its minimally invasive heart implant, making it the first to claim a U.S. green light to treat severe backflow through the aortic valve. And it gets to ...
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial's ...
SAN FRANCISCO -- Aortic valve regurgitation treated with the investigational JenaValve Trilogy appeared safe and effective in the ALIGN AR trial. The device met the safety benchmark, with a 26.7% rate ...
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results